This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

A Valuable Adjunct in the Management of Carcinoma of the Ureter

Luther W. Brady, MD; G. John Gislason, MD; Donald S. Faust, MD; Ismail Kazem, MD; John Antoniades, MD; James A. Davis, MD

JAMA. 1968;206(13):2871-2874.

Abstract
In the interval from 1948 through 1964, 34 patients with carcinoma of the ureter were seen. Six of these patients were referred for radiation therapy. Of this number, two received postoperative radiotherapy following biopsy of nonresectable tumor, two received postoperative radiotherapy for extensive regional disease where complete surgical extirpation was not possible, and two received radiotherapy for proved recurrences of disease. Significant periods with the patient free from disease can be obtained when adequate radiation dosages are employed, with three of five patients surviving five years without evidence of recurrence. Radiation therapy should be employed in those patients in whom only biopsy is possible, for those patients with extensive regional disease where surgical extirpation is not complete, and for recurrences following definitive surgical management.

Author Affiliations
From the departments of radiology (Division of Radiation Therapy and Nuclear Medicine) and urology, the Hahnemann Medical College and Hospital, Philadelphia. Dr. Faust is an advanced clinical fellow in radiation therapy of the American Cancer Society; Dr. Davis is a fellow in urology.

Footnotes
Reprint requests to 230 N Broad St, Philadelphia 19102 (Dr. Brady).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Comment: The Other Urinary Tract Cancer: Cancer of the Ureter
Rubin
JAMA 1969;207:1138-1139.
ABSTRACT